WASHINGTON, March 15 -- The U.S. Department of Health and Human Services' Food and Drug Administration announced that it expects to award a cooperative agreement for the expansion of opioids system modeling efforts to address fentanyl, stimulants and polysubstance use. The agency description of the cooperative agreement states: "The purpose of this funding opportunity is to expand on the FDA's modeling efforts to more comprehensively address fentanyl, stimulants and polysubstance use and their  more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' Food and Drug Administration announced that it expects to award a cooperative agreement for the development and maintenance of an organizational infrastructure to support a broad-based public-private partnership under FDA's Pediatric Anesthesia Safety Initiative. The award ceiling for this funding opportunity is $450,000. The categories of funding activity are a) natural resources and b) science and technology and other r more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award up to three cooperative agreements for early-stage development of data science technologies for infectious and immune-mediated diseases. The agency description of the cooperative agreement states: "The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the development of enabling data science technologies to improve the acq more ST

WASHINGTON, March 19 -- The U.S. Department of Health and Human Services' National Institutes of Health announced that it expects to award up to two cooperative agreements for the enhancement or sustainment of data science tools for infectious and immune-mediated disease. The agency description of the cooperative agreement states: "The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the enhancement and/or sustainment of high-value data science research soft more ST